Literature DB >> 362953

Response of Plasmodium falciparum in Sudan to oral chloroquine.

A H Omer.   

Abstract

The chloroquine sensitivity of Plasmodium falciparum was studied in two areas of Sudan. In the Gezira, 99.2% of the patients tested responded completely to the drug. Two patients (0.4%) and one patient (0.2%) showed, respectively, RI and RII responses. However, in those showing RI response reinfection could not be excluded. In an area of southern Sudan patients could only be followed-up for 7 days; nevertheless, this was sufficient to exclude the presence of RII and RIII responses there. This study also showed that malaria is a common cause of fever in Sudan, as over 90% of fever cases tested in the Gezira were positive for malaria and P. falciparum was the predominant species in these cases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 362953     DOI: 10.4269/ajtmh.1978.27.853

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

Review 1.  Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2012

2.  Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.

Authors:  Michela Menegon; Albadawi A Talha; Carlo Severini; Sayed M Elbushra; Ahmed A Mohamedani; Elfatih M Malik; Tarig A Mohamed; Walther H Wernsdorfer; Giancarlo Majori; Bakri Y M Nour
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 1. Results of in vivo and in vitro studies and of an ophthalmological survey.

Authors:  E Onori; D Payne; D Grab; B Grab; H I Horst; J Almeida Franco; H Joia
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

Review 4.  Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope.

Authors:  Hayder A Giha
Journal:  Parasitol Res       Date:  2009-12-15       Impact factor: 2.289

5.  The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.

Authors:  E Onori
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

6.  African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum.

Authors:  J M Carlin; J A Vande Waa; J B Jensen; M A Akood
Journal:  Z Parasitenkd       Date:  1984

7.  From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

Authors:  E M Malik; T A Mohamed; K A Elmardi; R M Mowien; A H Elhassan; S B Elamin; A A Mannan; E S Ahmed
Journal:  Malar J       Date:  2006-07-31       Impact factor: 2.979

8.  Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.

Authors:  W Zheng; H Jiang; Z Xiong; Z Jiang; H Chen
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

9.  Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.

Authors:  Nahla B Gadalla; Tajeldin M Abdallah; Sharanjeet Atwal; Colin J Sutherland; Ishag Adam
Journal:  Malar J       Date:  2013-07-19       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.